IPSC
Closed
Century Therapeutics Inc
0.543
-0.016 (-2.86%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.5587
Day's Range: 0.5401 - 0.5671
Send
sign up or login to leave a comment!
When Written:
3.47
Century Therapeutics Inc is a biotechnology company that was founded in 2018 and is headquartered in Philadelphia, Pennsylvania. The company is focused on developing transformative cell therapies for cancer.
Century Therapeutics Inc uses induced pluripotent stem cells (iPSCs) to create a scalable, off-the-shelf cell therapy platform. The company is developing a range of cell therapies for various types of cancer, including acute myeloid leukemia (AML), multiple myeloma, and solid tumors.
Century Therapeutics Inc is led by a team of experienced biotechnology executives and scientists, including CEO Lalo Flores, who previously served as the Head of the Cell Therapy Franchise at Novartis. The company has raised over $300 million in funding from investors, including Fidelity Management & Research Company, Casdin Capital, and Deerfield Management Company.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Century Therapeutics Inc uses induced pluripotent stem cells (iPSCs) to create a scalable, off-the-shelf cell therapy platform. The company is developing a range of cell therapies for various types of cancer, including acute myeloid leukemia (AML), multiple myeloma, and solid tumors.
Century Therapeutics Inc is led by a team of experienced biotechnology executives and scientists, including CEO Lalo Flores, who previously served as the Head of the Cell Therapy Franchise at Novartis. The company has raised over $300 million in funding from investors, including Fidelity Management & Research Company, Casdin Capital, and Deerfield Management Company.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








